Effectiveness and Adverse Events of Nirmatrelvir/Ritonavir Versus Molnupiravir for COVID-19 in Outpatient Setting: Multicenter Prospective Observational Study
2023Journal of Korean Medical ScienceJournalOpen access
10.3346/jkms.2023.38.e347Full text15 citations